Adma Biologics | ADMA - Pre Tax Profit

Stock Price
16.43
Daily Change
0.49 3.07%
Monthly
-12.70%
Yearly
-1.68%
Q1 Forecast
16.77

Adma Biologics reported $47.52M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Adma Biologics USD 47.52M 7.42M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Dynavax Technologies USD 28.42M 7.2M Sep/2025
Takeda JPY 133.86B 105.69B Dec/2025